Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 18, 2002

View Archived Issues

Epicyte partners with aaiPharma to develop topical monoclonal antibody

MalariVax phase I commences at U.S. and U.K. sites

Discovery of back-up HNE inhibitors detailed by GSK

E-selectin vaccine prevents stroke in rat model

Roche designs neuroprotective agents with reduced side effect liability

Sustained beneficial effects reported for tadalafil in men with ED

Research findings support use of KRP-197 for overactive bladder

Micrologix acquires antiviral product and technology portfolio

Incenta presents new cruzipain inhibitors for use in Chagas' disease

AWD-12-281 compares favorably with other PDE4 inhibitors in terms of safety margin

Novel IL-8 antagonists and their use in psoriasis, arthritis, etc.

Merck and Isis researchers identify new HCV NS5B polymerase inhibitors

New alpha4beta1/alpha4beta7 integrin antagonists identified at Almirall Prodesfarma

Coagulation factor inhibitors covered by Merck patent

Lipoxin A4 produced in human bronchial epithelium, exerts antiinflammatory effects

Phase III Tarceva trial in NSCLC completes enrollment

Pharmexa reacquires AutoVac(TM) TNF-alpha pharmaccine

European approval for Fosrenol delayed

SuperGen's decitabine awarded orphan drug status for sickle cell anemia

Tularik advances T-487 into phase I trials

Xigris evaluated in severe sepsis patients at low risk of death

Provigil improves ADHD symptoms in children

Therion licenses rights to ICAM-1 from Boehringer Ingelheim

Debiopharm and Biolex form recombinant human therapeutic protein collaboration

Dyax schedules second phase II trial of DX-88 in hereditary angioedema

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...